ClinicalTrials.gg
Not yet recruitingNCT06455982SAGE-2Updated Jun 13, 2024

Reduced Carbohydrates + Ketogenic Supplement on Energy Metabolism

An interventional study of reduced carbohydrate menu combined with ketogenic supplement in Healthy Aging, sponsored by Université de Sherbrooke. Not yet recruiting at 1 site in Canada. Open to participants aged 60 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-06-13.

Sponsored by Université de Sherbrooke · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Primary completion was expected by Dec 2024, 1 year 11 months ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Not applicable
Ages
60 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 18 studies in Ketosis by Université de Sherbrooke — 4 open to participants now, 5 under way, none of them phase 3. Ketosis · Université de Sherbrooke.

Planned enrollment
2nd of 15
30 · median 15
Started
2024
with 2 others
No phase
15 of 18
2 open now
Registered
15th of 18
by date

Among the 18 studies in Ketosis by Université de Sherbrooke, this one is the 2nd largest by planned enrollment of the 15 interventional ones that give a count, is one of 3 that started in 2024, is one of 15 with no phase, and was the 15th registered.

Ketosis

218 studies on the registry are indexed under Ketosis; 49 are open to participants now.

Browse Ketosis studies →

Open to participants now

4 of the 18 studies in Ketosis by Université de Sherbrooke are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 4 open studies →

Where they have run

Who these studies take

Of the 31 Ketosis studies recruiting now, 7 (23%) set no upper age limit and 21 (68%) stop at 75 or younger; 1 takes children under 18; 9 take healthy volunteers.

This study: 60 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 18 studies in Ketosis by Université de Sherbrooke, or all of them as a file.
02

Study summary

The present study will evaluate the effects on glucose, ketones and other blood biomarkers, cognition, quality of life, physical activity and well-being of a reduced carbohydrate diet paired with a ketogenic product for 2 months in a population living in a senior residence. This study follows the KetoHome (fall 2022) and SAGE (fall 2023) projects which assessed the feasibility, acceptability and effectiveness of a reduced carbohydrate intervention alone.

03

Conditions studied

  • Healthy Aging

Browse trials for

Keywords

  • Nutritional intervention
  • Glucose monitoring
  • Reduced carb diet
  • Energy metabolism
  • Ketones
04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Older men or women in a senior residence;
  • Understand, read and write French;
  • Have sufficient visual and hearing acuity to pass cognitive tests;
  • Available during the intervention period

Exclusion criteria

Exclusion Criteria:

  • \< 20;
  • T1 diabetic;
  • T2 insulin-dependent diabetic;
  • \< 20;
  • Weight loss >10% in the last 6 months involuntary or voluntary;
  • Known and uncontrolled hypoglycemia;
  • Moderate to severe digestive illnesses that can be aggravated by dietary changes;
  • Severe dysphagia;
  • Supplementation with MCT oil, ketone salts, ketone esters, adherence to the ketogenic diet, reduced carbohydrate diet, intermittent fasting or other diet or supplements that can significantly increase ketones in the last month;
  • Participation in other interventional research projects on nutrition or aimed at metabolic change simultaneously.
  • Medical condition that could prevent the participant from completing the study in the opinion of the doctor
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Delta of before/after the intervention

    2 months of reduced carbohydrate menu combined with a ketogenic MCT supplement

    Dietary Supplement: reduced carbohydrate menu combined with ketogenic supplement

Interventions

  • Dietary supplementreduced carbohydrate menu combined with ketogenic supplement

    Participants will eat a reduced carb menu for 2 months and they will take 15g of MCT in the morning and the evening for a total of 30g per day.

    Also known as: RCHO+MCT

06

What researchers measure

Primary outcomes

  1. Plasma glucose concentration

    To evaluate the possible improvement in mean glucose concentration following a reduction in carbohydrates combined with an MCT supplement in people living in a senoir residence for 2 months.

    Time frame: 2 months

  2. Plasma ketones concentration

    To evaluate the possible improvement in mean ketones concentration following a reduction in carbohydrates combined with an MCT supplement in people living in a senoir residence for 2 months.

    Time frame: 2 months

  3. Plasma insulin concentration

    To evaluate the possible improvement in mean insulin concentration following a reduction in carbohydrates combined with an MCT supplement in people living in a senoir residence for 2 months.

    Time frame: 2 months

Secondary outcomes

  1. Plasma triglycerides concentration

    To evaluate the possible improvement in mean triglycerides concentration following a reduction in carbohydrates combined with an MCT supplement in people living in a senoir residence for 2 months.

    Time frame: 2 months

  2. Plasma cholesterol concentration

    To evaluate the possible improvement in mean cholesterol concentration following a reduction in carbohydrates combined with an MCT supplement in people living in a senoir residence for 2 months.

    Time frame: 2 months

07

Study locations

1 site
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Sep 2024; primary completion for Dec 2024, 3 months later.

Of 99 non-industry interventional studies with no phase under Ketosis, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 24. This study's planned 3 months is below that.

Counting every sponsor, half of 103 studies reached it within 14 months; a quarter within 7 and three quarters within 24.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 6, 2024
First posted
Jun 13, 2024
StartEst.
Sep 5, 2024
Primary completionEst.
Dec 15, 2024
CompletionEst.
Dec 15, 2025
Last update
Jun 13, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 13, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06455982
Collaborators
Nestlé Health Science
Responsible party
Sponsor
First posted
Jun 13, 2024
Start date
Sep 5, 2024 (estimated)
Primary completion
Dec 15, 2024 (estimated)
Completion
Dec 15, 2025 (estimated)
Last update
Jun 13, 2024

Study contacts

Camille Vandenberghe
Contact
camille.vandenberghe@usherbrooke.ca
819-780-2220 ext. 45235

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion